Live feed08:00:00·787dPRReleasevia QuantisnowBioVie Awarded up to $13.1 Million in Funding from U.S. Department of Defense to Evaluate Bezisterim (NE3107) for the Treatment of Long COVIDByQuantisnow·Wall Street's wire, on your screen.BIVI· BioVie Inc.Health Care
